Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Year: 2010
Type: review
Source: Drug Discovery Today
Authors: Lawrence R. Dick, Paul E. Fleming
Institution: Takeda Oncology (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2091378741